Brenus Pharma has been selected to participate to HTID-Paris 2020 and got the opportunity to attend very interesting thematic conferences and to introduce its Stimulated Tumor Cells technology to worldwide innvestors and pharmaceutical companies involved in cancer.
Brenus Pharma at Health Tech Innovation Days – Paris
octobre 20, 2020